ObsEva SA OBSEF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 117.18M
- Market Cap
- $11,717.73
- Volume/Avg
- 115 / 7,411
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.obseva.com
Valuation
|
Metric
|
OBSEF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
OBSEF
|
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 2.23 |
Interest Coverage | −2.24 |
Quick Ratio
OBSEF
Profitability
|
Metric
|
OBSEF
|
|---|---|
Return on Assets (Normalized) | −41.53% |
Return on Equity (Normalized) | −227.14% |
Return on Invested Capital (Normalized) | −41.89% |
Return on Assets
OBSEF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|#KJVS?% | LOCK|zRF^l | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|hy>^zY | LOCK|H>T@< | $83B | |||
| Moderna Inc
MRNA
| LOCK|Nh!!!## | LOCK|?& | $80B | |||
| argenx SE ADR
ARGX
| LOCK|&&kwSW | LOCK|X<j | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|D<@@mC | LOCK|$c | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|&wV>lY | LOCK|@BF% | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|%&>rgl&G | LOCK|#<mDQ | $28B | |||
| Incyte Corp
INCY
| LOCK|@Ps#Ds | LOCK|LJL | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|ML^yf&v | LOCK|<! | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|$Wc!bR> | LOCK|xk | $14B |
United States